Trading Summary - August 15. Another satisfactory

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
159
Trading Summary - August 15.

Another satisfactory status quo day for $DIGX at .0003 x .0004 whilst awaiting updates with all the OTC whale traders in $DIGX busy elsewhere in the meantime.

The visible bid increased by 10M to 112M + plus probable other large hidden AON orders - with no fills of course.

There were no paint down attempts today as the 2 remaining manipulator / bashers clearly thought - incorrectly again of course - that their new fake stacked ask might dupe some small holders to sell for a loss at .0003.

The undercut ask at .0004 varied between a probable real 1M at the open up to 45M+ with possible fake elements added via NITE and CDEL later.

Whilst this figure might put off new traders who casually peruse L2 information without checking the main DD for $DIGX which is on this board, it will have no effect on the main whale trader shareholders who will still buy out any ask left at .0004 when we get the first update on the new company or whenever it suits them otherwise to increase their inventory of shares to use in the future into 2019.

The funds from interested traders watching $DIGX at all times are still sufficient to take out the .0004s + .0005s + .0006s in seconds to minutes at any time of their choosing as already seen in 2018 and multiple times in 2017.

We continue to wait for confirmation from the new CEO on the nature of the deal with Eco Innovation Group, Inc.

We can definitely expect to see a PR in due course and almost certainly a ticker change to one more appropriate to the name of the new company "Eco Innovation Group, Inc."

Asks in the 30M>50M range at each each .0001 price point to the upside are relatively easy to deal with on $DIGX as seen on all previous runs in 2017 and so far in 2018 as well - where they disappeared in seconds / minutes.

2018 Q2 ended on June 30 so we can look forward to another set of excellent results soon. In 2017, the Q2 results were filed on August 21 - only 4 trading days away now.

As always, anything could happen at anytime - particularly so with Tweets expected. So stay sharp if you don't already have all the shares you need to make your profit expectations on multiple runs up to end-2018 and beyond.

Prior warning and / or scanner alerts of any significant buys starting a run up will not be given on iHub but they will be alerted here immediately.

Content below the line are long-term comments and unchanged from the last update - relevant to those that are new here.

The company recommenced communication with shareholders on June 20 via Twitter - after silence since last August. It just announced the takeover by the new CEO [see earlier posts].

In the meantime, the company has been quietly getting on with banking significant profits - as seen in the 2017 Q4 and 2018 Q1 results - but now long term followers can look forward to updates on the next chapter.

Watch out for any PR making the excellent performance in the 2017 Annual Report and 2018 Q1 Report known to the wider investor / trading community.

The long-term whales who trade $DIGX will continue to buy shares at any price that makes sense to them to use on multiple runs throughout 2018. It is already known from posted comments and observation that at least 4 of the main whales bought shares - on the bid and on the ask - from the impatient at the end of 2017.

As predicted, at least 4 x whales who trade $DIGX continuously throughout each year were happy to take around 100M at .0003 when a few impatient people decided to trade for a loss at .0003 on December 14.

As predicted in October 2017, $DIGX was not allowed to go to the 2016 year-end low of .0002 ask at end-2017.

Any shares bought at .0006 should easily return 100%+ at some point in 2018.

The big boys in DIGX now probably already have an inventory of 50M>200M each for trading throughout 2018.

As the long-term followers - including at least 5 whales - control the majority of shares bought at .0003/4/5 - and they are not looking to sell anytime soon for less than the market cap - we can expect the "basher" / impatient ask amounts at any level below .0010 to get taken out at some point.

Of relevance to $DIGX in the long-term, there can now be no new notes issued to stocks currently under .01 (there have not been any new notes recently anyway) and any convertible debt selling is restricted to 20% of the average volume in the last 20 days.

Ludicrous claims by the notorious bashers on iHub - "RFB", "munimi", "surfkast:, "Crown Capital" and "Homebrew" - are clearly seen as such by all serious traders and now even by most iHubbers.

Money is never considered "dead" - a term misused by iHub basher morons - by the most successful traders in the OTC market when they know it will provide a significant return further down the line because they are in a position to understand and influence - through keen observation and record keeping - what volume of shares is likely to be made available for purchase at any particular level.

Indeed that has already proved to be the case in 2018 for those that have been buying off the bottom since 2017 Q3 with $DIGX already showing gains of 100% > 20% - depending on entry at .0003/4/5 - when it reached .0006 and trading significant amounts there (82M) on June 26.




American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CME Group Smashes FX Open Interest Record Again

Updated Category News Views 4

Shattering Records: CME Group's Latest Milestone Well, here's a juicy nugget for your investment playbook. On September 4, 2026, CME Group proved, once again, why they're the big dog in the derivatives yard, announcing a new record in FX open interest—4,410,167 contracts! This tops the previous mark of 4,269,622 contracts set just a few months back. The futures and...

Continue Reading
Coastal Property Realities: A Deep Dive into Ownership

Updated Category News Views 4

Buying Coastal Property: A Balancing Act Ah, the dream of owning a piece of the beach in sunny South Florida. It sounds glamorous—something to brag about at the next family gathering. But let me tell you, diving into coastal property ownership isn't just about sipping cocktails by the ocean. It's about handling a fair share of headaches most folks don't anticipate....

Continue Reading
York Space Systems Faces Investor Lawsuit Over Claims

Updated Category News Views 1

Allegations Stir the Pot: York Space Systems Under Fire Now we're sailing into choppy waters with York Space Systems (YSS). There's a full-blown ruckus stirring as investors take aim at the company, thanks to a class action lawsuit alleging securities fraud. The legal beagles from Glancy Prongay Wolke & Rotter LLP are spearheading this effort, claiming that York pulled...

Continue Reading
Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 3

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 3

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
GBC 2026 Wraps Up: Korea Eyes Bio Industry Leadership

Updated Category News Views 3

GBC 2026: Korea's Giant Leap in Bio Innovation Well, there wasn't a dull moment at the 'Global Bio Conference 2026' in Seoul. Picture a melting pot where 5,600 participants from 19 countries converged to chat about the latest and greatest in biopharma innovation and regulatory strategies. That's not a setup you see every day, mind you. This event packed the room with...

Continue Reading
Lyon Biennale 2026: Art, Dreams, and Lyon's Magic

Updated Category News Views 3

Unveiling the Art Spectacle in Lyon Alright, buckle up folks, because the 18th Lyon Biennale – Contemporary Art is about to take the stage in grand fashion. Starting on the 19th of September, this art fiesta is not just any exhibit; it's an eleven-venue citywide takeover that runs until the 13th of December, and it is poised to shake up the art scene like a good splash...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 9

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Tech Breakthroughs in Cancer and Space Energy Aired

Updated Category News Views 3

Science and Technology at the Forefront Saturday nights usually have folks kicking back with some reality shows or maybe cheering on their favorite sports team. But this September 12, savvy viewers have a chance to dive deep into the guts of cutting-edge science and tech on Bloomberg Television. We're talking about 'Advancements with Ted Danson'—where science isn’t...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 2

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading

Top 5 Most Recently Viewed Articles

Breakthrough Gene Therapy Study Offers Hope for Danon Disease

Updated Category News Views 110

Revolutionary Advances in Gene Therapy for Danon Disease Recent findings from groundbreaking research at Children's Hospital of Philadelphia reveal a promising new approach in tackling Danon disease, a complex genetic disorder predominantly affecting young males. The study not only highlights the potential of gene therapy—specifically a novel treatment known as...

Continue Reading
Biohaven Doses First Patient with Innovative BHV-8100

Updated Category News Views 4

Biohaven Breaks New Ground with BHV-8100 There’s a fresh buzz in the biopharma world as Biohaven Ltd. kicks off first-in-human dosing for their novel drug, BHV-8100. This is no small feat, and it could potentially shake up the landscape of treatments for systemic and central nervous system disorders. You know there’s weight behind a drug when it’s aiming for those...

Continue Reading
Nasdaq Sets Date for 2026 Investor Day Event

Updated Category News Views 372

Exciting Announcement from Nasdaq Nasdaq recently shared significant news regarding its upcoming 2026 Investor Day. Scheduled for the morning of February 25, 2026, this highly anticipated event will take place at the Nasdaq Global Headquarters in Times Square. This annual gathering is essential for investors as it provides insights into the company's strategic direction...

Continue Reading
Acreage Holdings Restructures Debt Agreement for Growth

Updated Category News Views 89

Acreage Holdings Restructures Debt Agreement with Canopy USA Acreage Holdings (OTC: ACRGF), Inc. is a diversified cannabis company, recently announced a strategic amendment to its debt agreement with Canopy USA, LLC, which impacts the payment terms of its outstanding obligations. This pivotal financial maneuver came into effect recently and is a reflection of the...

Continue Reading
Chlorella Market Projected Growth and Nutritional Benefits

Updated Category News Views 233

Understanding the Growth of the Chlorella Market Chlorella occupies an important place in the sphere of superfoods. This vibrant freshwater alga, famous for its rich nutritional profile, plays a vital role in the health and wellness trend that is sweeping across the globe. It is known for its presence in pills, powders, capsules, and liquid extracts, marking its...

Continue Reading